Uricase de Candida sp., recombinant, exprimé en E. coli, poudre lyophilisée ,>=2 unités/mg solide

Code: u0880-250un D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Suitable for the determination of uric acid in clinical analysis.

General description

Uricase deficient mice develop uric...


en savoir plus

Votre prix
£165.00 EACH
DEMANDER

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Suitable for the determination of uric acid in clinical analysis.

General description

Uricase deficient mice develop uric acid nephropathy and diabetes insipidus which can be mitigated with recombinant uricase treatment.

Packaging

250, 1000 units in glass bottle

Physical form

Powder; contains citrate and sucrose

Unit Definition

One unit will oxidize 1.0 µmole of uric acid to allantoin per minute at pH 8.5 at 25 °C.

formlyophilized powder
InChI keyVPXDHZMLJOJKOX-UHFFFAOYSA-N
InChI1S/C18H23N4O14P.H3N/c23-5-7-14(13(28)16(34-7)22-4-2-10(25)20-18(22)30)36-37(31,32)33-6-8-11(26)12(27)15(35-8)21-3-1-9(24)19-17(21)29;/h1-4,7-8,11-16,23,26-28H,5-6H2,(H,31,32)(H,19,24,29)(H,20,25,30);1H3
mol wt35 kDa by SDS-PAGE
Quality Level200
recombinantexpressed in E. coli
specific activity≥2 units/mg solid
storage temp.−20°C
Code
Description
Unité de vente
Prix annoncé
Qté
U0880-1000UN
Uricase de Candida sp., recombinant, exprimé en E. coli, poudre lyophilisée ,>=2 unités/mg solide

Unité:EACH
Prix annoncé: £410.00
Source:Prix annoncé
AJOUTER
Cas Number9002-12-4
Ce produit répond aux critères suivants: